Before reading the job post, we encourage you to watch this video about our company. It gives you an inside look at how we started, the team and culture that made us successful, and where we're going. It's easy to read a job post and apply, but people often wonder about the culture and whether they would fit in. If you want to call Harrow your home and genuinely want to be part of a family and something big, then we encourage you to click this link and get to know us.
Who is Harrow?
Harrow (Nasdaq: HROW) is a leading North American ophthalmic-focused pharmaceutical company. Harrow is an incredible entrepreneurial company – where we celebrate the ability of every member of the Harrow Family to be the CEO of their job. Harrow’s values have driven interest over the past decade in attracting high-performing professionals in a variety of disciplines. Members of our Harrow Family often express their pride in being a part of our commitment to (1) innovation, (2) patient access to affordable medicines, and (3) our track record of having never turned down an ophthalmologist doing mission work around the world – providing free medicines in support of mission work aimed at giving or maintaining the gift of sight to those most in need. We encourage you to learn more about Harrow and its unique culture to see if you’re the right person to help contribute as we build a truly exceptional company, one we are all so proud of!
Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including:
- An expanding Posterior Portfolio including IHEEZO® and TRIESENCE®
- A broad Dry Eye Disease product line, led by VEVYE® and bolstered by well-known adjacent ocular surface disease products such as FLAREX® and TOBRADEX® ST
- A Specialty Anterior Segment product line, which includes various high-need and utility products such as ILEVRO®, NEVANAC®, and VERKAZIA®
Job Summary
The Investor Relations Specialist will work directly with the Vice President of Communications and Investor Relations to help manage communications between Harrow and the investment community, potential investors, shareholders, company employees, and vendors. This will include drafting, editing and issuing press releases, organizing investor roadshows and conferences, preparing and distributing financial reports and presentations, and organizing investor events. The IR Specialist will schedule meetings and calls with potential investors, analysts, and shareholders, facilitating effective communication and relationship-building. Their responsibilities also include maintaining investor databases and supporting the execution of investor relations strategies to enhance shareholder confidence and engagement. The ideal candidate has exceptional communication skills and is detail-oriented, organized, and able to work effectively in a fast‑paced environment.
Core Responsibilities
- Work with VP of Communications & Investor Relations to execute IR strategic plan.
- Assist in drafting, editing and issuing press releases, in compliance with regulatory guidelines, and distributing to media, investors, and related parties.
- Manage logistics for quarterly earnings calls, investor meetings, roadshows, and investor conferences and events.
- Maintain investor databases and ensure data integrity for investor relations activities.
- Assist in conducting financial analysis and benchmarking against industry peers.
- Collaborate with internal teams, including finance and legal, to support investor relations initiatives.
- Prepare materials for annual general meetings and other shareholder events.
- Work with Transfer Agent on stock-related activities.
- Stay updated on market trends, regulatory developments, and competitor activities affecting investor relations.
- Support the IR team in special projects, such as investor targeting and investor perception studies.
- Demonstrate strong communication skills to interact effectively with investors and internal stakeholders.
- Possesses financial acumen with an understanding of financial statements and key performance indicators.
- Exhibits knowledge of investor relations principles, practices, and regulatory requirements.
- Pays attention to detail to ensure accuracy in financial reports and investor communications.
- Demonstrates strong organizational skills to manage multiple tasks and meet deadlines.
- Utilizes analytical skills to conduct financial analysis and interpret market data.
- Applies problem-solving abilities to address investor inquiries and resolve issues efficiently.
- Proficient in using IR software, financial databases, and Microsoft Office Suite.
- Collaborates effectively with cross-functional teams to achieve investor relations objective.
Qualifications & Requirements
- Bachelor’s degree and/or relevant industry experience required.
- 3+ years of support experience in investor relations, finance, or communications. Familiarity with press release distribution platforms (Business Wire, GlobeNewswire, PR Newswire) preferred.
- Strong organizational and time-management skills with the ability to manage a heavy workload and aggressive timelines in a timely manner, prioritize and work under pressure.
- Excellent verbal and written communication skills.
- Ability to demonstrate initiative and simultaneously achieve multiple tasks.
- Uncompromising ability to maintain confidentiality, exercise sound judgment and the highest level of discretion; knowledge of SEC and disclosure requirements preferred.
Position Type
- On-Site
Travel
- Up to 5%
Top Skills
What We Do
Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market.
Our mission as a growing leader in the ophthalmic healthcare market is driven by two core values: (1) unyielding dedication to innovation and (2) a mission of providing affordable and accessible medications. We pride ourselves on closely listening to the needs of providers and their patients, so we can do everything in our power to address them with high-quality products and services.
Our worthwhile mission is producing amazing financial results, and because we’ve produced a 72% compound annual growth rate for our first eight years in business, we are one of the fastest-growing ophthalmic pharmaceutical companies in the United States.
.jpg)
.png)
